CGEM - Cullinan Therapeutics, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $-0.80
|
Rev Est: $5.0M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$30.83
DETAILS
HIGH:
$38.00
LOW:
$26.00
MEDIAN:
$30.00
CONSENSUS:
$30.83
UPSIDE:
116.05%
Market Cap:
843.02M
Volume:
969,679
Avg Volume:
1,003,598
52 Week Range:
5.68-14.55
Sector:
Healthcare
Industry:
Medical - Pharmaceuticals
Beta:
-0.10
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
111
IPO Date:
2021-01-08
EPS (TTM):
-3.11
P/E Ratio:
-3.91
Revenue (TTM):
N/A
Total Assets:
621.82M
Total Debt:
2.15M
Cash & Equiv:
83.00M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-28.3%
Debt/Equity:
0.00
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $-0.77 | $-0.95 | +18.9% | — | $5.6M | — |
| 2025-08-07 | $-1.07 | $-0.83 | -28.9% | — | — | — |
| 2025-05-08 | $-0.74 | $-0.78 | +5.1% | — | — | — |
| 2025-02-27 | $-0.73 | $-0.75 | +2.7% | — | — | — |
| 2024-11-07 | $-0.69 | $-0.78 | +11.5% | — | — | — |
| 2024-08-08 | $-0.75 | $-0.73 | -2.7% | — | — | — |
| 2024-05-15 | $-0.86 | $-0.90 | +4.4% | — | — | — |
| 2024-03-14 | $-0.54 | $-0.96 | +43.7% | — | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 18.94M | 0 | 0 | 0 |
| Net Income | (167.38M) | (153.16M) | 111.21M | (65.57M) | (51.80M) | (20.04M) | (14.19M) |
| EPS | -3.11 | -3.69 | 2.46 | -1.48 | -1.19 | -19.70 | -17.74 |
| Total Assets | 621.82M | 484.18M | 561.12M | 437.19M | 214.71M | 100.46M | 34.64M |
| Total Debt | 2.15M | 3.59M | 5.19M | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 83.00M | 98.43M | 156.15M | 59.77M | 168.20M | 63.25M | 33.83M |
| Operating Cash Flow | (145.30M) | (134.28M) | (126.66M) | (43.43M) | (29.77M) | (20.90M) | (13.55M) |
| Free Cash Flow | (145.30M) | (134.48M) | (127.80M) | (44.02M) | (29.78M) | (20.92M) | (13.81M) |
| FCF per Share | -2.70 | -3.24 | -2.83 | -0.99 | -0.68 | -20.57 | -17.26 |
| Book Value | 590.33M | 453.70M | 535.03M | 424.97M | 199.01M | (40.77M) | (20.65M) |
| Cash & ST Investments | 398.98M | 467.07M | 467.29M | 290.47M | 210.21M | 98.63M | 33.83M |
| ROC Equity | -0.28 | -0.34 | 0.21 | -0.15 | -0.26 | N/A | N/A |